Social Media Ideas for Drug Discovery

From Discovery to Development in Emerging Modalities

ProBio is building flexible platforms for multispecific antibodies, ADCs, and other advanced therapeutic approaches. The post From Discovery to Development in Emerging Modalities a...

Multiomics Mass Spec Workflows in Drug Discovery

Advances in end-to-end multiomics platforms and the underlying scientific knowledge now enable faster and more precise biomarker discovery, mechanistic insight generation, and ther...

Molecular editing method could speed drug discovery

Scientists unveiled a reaction that swaps key carbon groups in complex compounds, offering a faster route to test new medicine candidates.

Success Stories: Accelerating Cancer Drug Discovery

As researchers work to develop new cancer treatments, one of the biggest challenges is identifying promising drug candidates quickly and efficiently. Now, researchers at Purdue Uni...

<![CDATA[Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI]]>

ZoBio Introduces DNA-Encoded Library Service for Exploratory Drug Discovery Programs

ZoBio maintains that unlike transactional DEL screening approaches that focus solely on hit generation, its platform is designed to deliver biologically relevant, structurally char...

<![CDATA[Evogene Announces AI-Powered Small Molecule Discovery Focused Partnership with Blavatnik Center for Drug Di...

Harrington Discovery Institute Uncovers Novel Drug Targets for Challenging Cancer Types

Despite remarkable progress in medical science, the prognosis for most patients diagnosed with advanced-stage cancers remains bleak. The challenge lies not only in the complexity o...

Illuminating the Drug Development Path with Cell-Based Reporter Assays

In early discovery, researchers use high-throughput screening (HTS) to identify active compounds in a biologically relevant context. During lead characterization and validation, th...

Macrocyclic Peptide Drugs Unlocked, Membrane Permeability Screened at Scale

A new method screens large libraries of synthetic cyclic peptides to identify compounds that can enter cells for therapeutic effect, opening avenues for a modality that combines th...

The hidden innovation system behind drug repurposing 

Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of research starts. The post The hidden innovation system be...

AI Can Accelerate Discovery — Development Still Decides What Advances

AI will continue changing how small molecules are discovered, but the candidates that generate the most interest in silico still have to succeed under real development conditions....

Growth in species discoveries fuels hopes for new drugs

Mass Spectrometry’s Discovery Revolution

Next-generation MS platforms are transforming drug discovery by revealing complex biology earlier, faster, and at unprecedented depth. The post Mass Spectrometry’s Discovery Revolu...

The Confidence Gap: Why Drug Discovery’s Data Explosion Hasn’t Solved Its Billion-Dollar Decision Problem

In this thought leader piece Laurence Arnold, PhD, head of R&D at Pelago Bioscience, discusses prioritizing proof over progress, so decision-makers can fail faster–and smarter....

AI in Drug Discovery: Surveying the Breadth of the Challenges

AI can speed up drug discovery and decrease attrition rates in the clinic, but it is important to recognize that both are tall orders. The companies that will benefit most are thos...

Skape Bio Unlocks Generalizable GPCR Drugs Using AI Protein Design

David Baker’s latest company is making medicines for a huge protein family once deemed undruggable. A new study generated miniproteins that target GPCRs across a diversity of recep...

Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transfor...

Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in know...

AI Designs Miniprotein Switches for GPCR Targeting

New AI‑designed miniproteins precisely modulate GPCR signaling and reveal a new "receptor diversion" microscopy-based screening system for targeting receptors long considered diffi...

AI Predicts Gene Regulation for Drug Discovery Using Condensate Morphology

Deep learning unveils how drugs affect the dynamics of key structures within the cell. A new study maps condensate morphology to functional outcomes and sheds light on markers of h...

Brain-Targeted Drug Discovery Barriers Drive Deep Science Ventures and Medicines Discovery Catapult Deal

The partnership’s first phase will see a review of the current medicines landscape conducted to identify opportunities for innovation. This information will be used to find systemi...

Collaborative Drug Discovery Inks Deal with Eli Lilly to Accelerate Biotech Innovation

CDD and Lilly say their agreement paves the way for the planned integration of Lilly TuneLab in both the core and AI modules within CDD Vault for biotech companies that opt into th...

Texas A&M Researchers Develop Quantum Technique for Drug Discovery

Insider Brief It’s one thing to design a pharmaceutical drug. It’s another to know if and why it actually works. Not on paper or in a computer model. But inside the chaotic world o...

Blue Light and Chemistry Simplify Complex Drug Production Steps

In the quest for faster and more efficient drug discovery, researchers have uncovered a novel method to enhance molecular complexity using a surprisingly straightforward tool: blue...